Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Everledger Launches Anti-Tamper Bottle Closures for The Wine and Spirits Industry
Final, full-dress rehearsal of grand parade for 50th anniversary of National Reunification held in HCM City 3.